Chromadex Share Price Today
(NASDAQ: CDXC)

Name: Chromadex Share Price Today (NASDAQ: CDXC) - Chromadex Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Chromadex share price is $8.55 & ₹744.41 as on 6 Mar 2025, 2.30 'hrs' IST

$8.55

▲

2.95

(52.68%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Chromadex share price in Dollar and Rupees. Guide to invest in Chromadex stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Chromadex, along with analyst recommendations, forecasts, and comprehensive financials.

Chromadex share price movements

Today's Low: $7.02
Today's High: $9.09
$8.55
17.89%
Downside
Day's Volatility :22.77%
Upside
5.94%
52 Weeks Low: $1.57
52 Weeks High: $9.18
$8.55
81.64%
Downside
52 Weeks Volatility :82.9%
Upside
6.86%

Chromadex (CDXC) Returns

Period	Chromadex Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	28.38%	3.7%	0.0%
6 Months	162.27%	-2.8%	0.0%
1 Year	391.38%	2.5%	0.0%
3 Years	242.0%	12.9%	-11.6%

Chromadex (CDXC) Key Statistics

in dollars & INR

Previous Close	$5.6
Open	$6.71
Today's High	$9.09
Today's Low	$7.02
Market Capitalization	$653.1M
Today's Volume	$18.7M
52 Week High	$9.18
52 Week Low	$1.57
Revenue TTM	$91.7M
EBITDA	$1.3M
Earnings Per Share (EPS)	$0.02
PE Ratio	427.5
Profit Margin	1.62%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	4.82%

How to invest in Chromadex Stock (CDXC) from India?

It is very easy for Indian residents to invest directly in Chromadex from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Chromadex stock in both Indian Rupees (INR) and US Dollars (USD). Search for Chromadex or CDXC on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Chromadex or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Chromadex shares which would translate to 0.102 fractional shares of Chromadex as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Chromadex, in just a few clicks!

Returns in Chromadex (CDXC) for Indian investors in Rupees

The Chromadex stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Chromadex investment value today

Current value as on today

₹4,96,444

Returns

₹3,96,444

(+396.44%)

Returns from Chromadex Stock

₹3,91,379 (+391.38%)

Dollar Returns

₹5,065 (+5.06%)

Indian investors sentiment towards Chromadex (CDXC)

-64%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Chromadex Stock from India on INDmoney has decreased by -64% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Chromadex

BlackRock Inc
4.73%
Vanguard Group Inc
4.44%
Tieton Capital Management, LLC
3.39%
ICONIQ Capital, LLC
1.70%
Geode Capital Management, LLC
1.51%
D. E. Shaw & Co LP
1.32%

Analyst Recommendation on Chromadex

Buy

88%Buy

11%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Chromadex(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Chromadex Stock (CDXC)

What analysts predicted

Downside of 6.9%

Target:

$7.96

Current:

$8.55

Insights on Chromadex Stock (Ticker Symbol: CDXC)

Price Movement
In the last 7 days, CDXC stock has moved up by 57.2%
Decreasing Revenue
Revenue is down for the last 2 quarters, 34.92M → 18.19M (in $), with an average decrease of 47.9% per quarter
Increasing Net Profit
Netprofit is up for the last 4 quarters, -492.0K → 7.17M (in $), with an average increase of 1118.2% per quarter

CDXC Chromadex Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$46.3M	↑ 46.69%
Net Income	$-31.5M	↓ 5.54%
Net Profit Margin	-67.99%	↑ 37.58%

	FY20	Y/Y Change
Revenue	$59.3M	↑ 28.01%
Net Income	$-18.5M	↓ 41.27%
Net Profit Margin	-31.19%	↑ 36.8%

	FY21	Y/Y Change
Revenue	$67.4M	↑ 13.82%
Net Income	$-25.6M	↑ 38.27%
Net Profit Margin	-37.89%	↓ 6.7%

	FY22	Y/Y Change
Revenue	$72.1M	↑ 6.82%
Net Income	$-14.4M	↓ 43.46%
Net Profit Margin	-20.05%	↑ 17.84%

	FY23	Y/Y Change
Revenue	$83.6M	↑ 15.99%
Net Income	$-4.9M	↓ 65.82%
Net Profit Margin	-5.91%	↑ 14.14%

	FY24	Y/Y Change
Revenue	$61.6M	↓ 26.31%
Net Income	$8.6M	↓ 273.15%
Net Profit Margin	13.88%	↑ 19.79%

	Q3 FY23	Q/Q Change
Revenue	$19.5M	↓ 4.07%
Net Income	$-959.0K	↓ 56.23%
Net Profit Margin	-4.92%	↑ 5.86%

	Q4 FY23	Q/Q Change
Revenue	$21.2M	↑ 8.73%
Net Income	$114.0K	↓ 111.89%
Net Profit Margin	0.54%	↑ 5.46%

	Q1 FY24	Q/Q Change
Revenue	$22.2M	↑ 4.52%
Net Income	$-492.0K	↓ 531.58%
Net Profit Margin	-2.22%	↓ 2.76%

	Q2 FY24	Q/Q Change
Revenue	$22.7M	↑ 2.65%
Net Income	$-15.0K	↓ 96.95%
Net Profit Margin	-0.07%	↑ 2.15%

	Q3 FY24	Q/Q Change
Revenue	$34.9M	↑ 53.57%
Net Income	$1.9M	↓ 12620.0%
Net Profit Margin	5.38%	↑ 5.45%

	Q4 FY24	Q/Q Change
Revenue	$18.2M	↓ 47.89%
Net Income	$7.2M	↑ 282.27%
Net Profit Margin	39.45%	↑ 34.07%

	FY19	Y/Y Change
Profit	$25.8M	↑ 60.5%

	FY20	Y/Y Change
Profit	$35.3M	↑ 36.89%

	FY21	Y/Y Change
Profit	$41.5M	↑ 17.62%

	FY22	Y/Y Change
Profit	$42.8M	↑ 3.15%

	FY23	Y/Y Change
Profit	$50.8M	↑ 18.65%

	FY24	Y/Y Change
Profit	$61.6M	↑ 21.28%

	Q3 FY23	Q/Q Change
Profit	$12.0M	↓ 3.13%

	Q4 FY23	Q/Q Change
Profit	$12.9M	↑ 8.09%

	Q1 FY24	Q/Q Change
Profit	$13.5M	↑ 4.01%

	Q2 FY24	Q/Q Change
Profit	$13.7M	↑ 1.76%

	Q3 FY24	Q/Q Change
Profit	$16.2M	↑ 18.6%

	Q4 FY24	Q/Q Change
Profit	$18.2M	↑ 12.05%

	FY19	Y/Y Change
Operating Cash Flow	$-20.4M	↓ 2.24%
Investing Cash Flow	$-249.0K	↓ 85.97%
Financing Cash Flow	$16.9M	↓ 18860.0%

	FY20	Y/Y Change
Operating Cash Flow	$-10.6M	↓ 48.14%
Investing Cash Flow	$-165.0K	↓ 33.73%
Financing Cash Flow	$8.7M	↓ 48.77%

	FY21	Y/Y Change
Operating Cash Flow	$-24.2M	↑ 127.95%
Investing Cash Flow	$-409.0K	↑ 147.88%
Financing Cash Flow	$36.1M	↑ 317.27%

	FY22	Y/Y Change
Operating Cash Flow	$-15.1M	↓ 37.52%
Investing Cash Flow	$-334.0K	↓ 18.34%
Financing Cash Flow	$7.7M	↓ 78.79%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$3.3M	↑ 17.48%
Investing Cash Flow	$-5.0K	↓ 94.51%
Financing Cash Flow	$-10.0K	↑ 900.0%

Chromadex Technicals Summary

Sell

Neutral

Buy

Chromadex is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Chromadex (CDXC) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Chromadex Corp	55.31%	162.27%	391.38%	242.0%	2.03%
Kraft Heinz Company, The	7.98%	-14.23%	-12.33%	-22.81%	29.34%
Mccormick & Company, Incorporated	7.61%	-0.37%	21.11%	-20.5%	14.88%
Hormel Foods Corporation	-2.14%	-10.43%	-15.88%	-44.9%	-33.75%
General Mills, Inc.	3.48%	-18.19%	-6.56%	-9.92%	12.6%
Kellanova	0.76%	2.72%	52.93%	24.92%	31.98%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Chromadex Corp	427.5	427.5	0.0	0.12	0.05	0.01	NA	0.45
Kraft Heinz Company, The	13.83	13.83	0.9	2.77	0.06	0.04	0.05	41.16
Mccormick & Company, Incorporated	29.0	29.0	2.85	3.08	0.15	0.05	0.02	19.74
Hormel Foods Corporation	20.84	20.84	2.99	1.61	0.1	0.05	0.04	14.6
General Mills, Inc.	13.25	13.25	3.56	4.36	0.27	0.07	0.04	16.66
Kellanova	21.28	21.28	1.68	3.92	0.37	0.08	0.03	10.94

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Chromadex Corp	Buy	$653.1M	2.03%	427.5	1.62%
Kraft Heinz Company, The	Buy	$37.0B	29.34%	13.83	10.62%
Mccormick & Company, Incorporated	Hold	$22.1B	14.88%	29.0	11.73%
Hormel Foods Corporation	Hold	$15.8B	-33.75%	20.84	6.35%
General Mills, Inc.	Hold	$33.6B	12.6%	13.25	13.08%
Kellanova	Hold	$28.4B	31.98%	21.28	10.53%

About Chromadex

ChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and Immulina, a spirulina extract with predominant active compounds of Braun-type lipoproteins for supporting human immune function. In addition, it offers phytochemical reference standards, and other research and development services. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, ShopHQ, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation was founded in 1999 and is headquartered in Los Angeles, California.

Organization	Chromadex
Employees	106
CEO	Mr. Robert N. Fried
Industry	Process Industries

Management People of Chromadex

Name	Title
Mr. Frank Louis Jaksch Jr.	Co-Founder & Chairman
Mr. Robert N. Fried	CEO & Director
Mr. Ozan Pamir C.F.A.	CFO & Principal Accounting Officer
Dr. Andrew Shao Ph.D.	Senior Vice President of Global Regulatory & Scientific Affairs
Mr. Carlos Lopez	Senior VP & General Counsel
Ms. Michiko Kelley	Chief Marketing Officer
Ms. Chu Yan	Managing Director of Asia Pacific
Kendall Knysch	Head of Media Relations & Partnerships
Mr. James Lee	Controller

Important FAQs about investing in CDXC Stock from India :

What is Chromadex share price today?

Chromadex share price today stands at $8.55, Open: $6.71 ; Previous Close: $5.60 ; High: $9.09 ; Low: $7.02 ; 52 Week High: $9.18 ; 52 Week Low: $1.57.

The stock opens at $6.71, after a previous close of $5.60. The stock reached a daily high of $9.09 and a low of $7.02, with a 52-week high of $9.18 and a 52-week low of $1.57.

Can Indians buy Chromadex shares?

Yes, Indians can invest in the Chromadex (CDXC) from India.

With INDmoney, you can buy Chromadex at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Chromadex at zero transaction cost.

How can I buy Chromadex shares from India?

It is very easy to buy Chromadex from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Chromadex (CDXC) be purchased?

Yes, you can buy fractional shares of Chromadex with INDmoney app.

What are the documents required to start investing in Chromadex stocks?

To start investing in Chromadex, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.